An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride)
- 1 August 1988
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (5) , 9C-17C
- https://doi.org/10.1016/s0002-9149(88)80061-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Regional Distribution of β-Adrenoceptors in the Human HeartJournal of Cardiovascular Pharmacology, 1986
- Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.Circulation Research, 1986
- Dopexamine: a novel agonist at peripheral dopamine receptors and β2‐adrenoceptorsBritish Journal of Pharmacology, 1985
- Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.Circulation, 1982
- CARDIOVASCULAR DOPAMINE RECEPTORS: PHYSIOLOGICAL, PHARMACOLOGICAL AND THERAPEUTIC IMPLICATIONSJournal of Autonomic Pharmacology, 1982
- A New Inotropic Drug: Its Promise and a CautionNew England Journal of Medicine, 1978
- Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle.Circulation, 1978
- Afterload reduction and cardiac performanceThe American Journal of Medicine, 1978
- A Comparison of the Vascular Dopamine Receptor with Other Dopamine ReceptorsAnnual Review of Pharmacology and Toxicology, 1978
- Salbutamol: agonistic and antagonistic activity at β-adrenoceptor sitesJournal of Pharmacy and Pharmacology, 1973